October 13, 2022 October 13, 2022Categories Institution SpotlightsInstitution Spotlight: Michigan Cancer Research Consortium NCORPA Standing Main Member of ECOG-ACRIN since 1983
August 16, 2022 August 16, 2022Categories From the Co-ChairsFrom the Co-Chairs, August 2022President Biden to appoint Dr. Monica Bertagnolli as NCI Director; NCI-MATCH trial data leads to FDA drug approval
November 16, 2021 November 16, 2021Categories Special Topics30 Member Networks and Programs Receive Commendations in 2021 for Outstanding Research PerformanceIn an annual evaluation, 30 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
November 16, 2021 November 16, 2021Categories News in BriefNews in Brief, November 2021Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
May 28, 2021 May 28, 2021Categories Special TopicsECOG-ACRIN Recognizes 22 Member Networks and Programs for Outstanding Research PerformanceIn an annual evaluation, 22 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
May 28, 2021 May 28, 2021Categories PeopleECOG-ACRIN Names Vanderbilt University’s Christine Lovly as Its 2021 Young Investigator of the YearDr. Lovly is the recipient of the 2021 ECOG-ACRIN Young Investigator Award, a highly prestigious recognition of research excellence
May 28, 2021 May 28, 2021Categories Trial ResultsECOG-ACRIN and PrECOG Research at ASCO 2021Researchers with the ECOG-ACRIN Cancer Research Group and PrECOG, LLC will present a wide range of research findings at the 2021 ASCO Annual Meeting
April 27, 2021 April 27, 2021Categories Institution SpotlightsInstitution Spotlight: Sylvester Comprehensive Cancer Center at the University of MiamiA Standing Main Member of ECOG-ACRIN since 2005
December 14, 2020 December 14, 2020Categories PeopleECOG-ACRIN Names University of Pennsylvania’s Bonnie Ky As Its Young Investigator of the YearAlready among the most influential thought leaders in cardio-oncology, Dr. Ky is the first in this field to receive the Group’s highest research distinction